UniProt ID | PRIO_HUMAN | |
---|---|---|
UniProt AC | P04156 | |
Protein Name | Major prion protein | |
Gene Name | PRNP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 253 | |
Subcellular Localization |
Cell membrane Lipid-anchor, GPI-anchor . Golgi apparatus . Targeted to lipid rafts via association with the heparan sulfate chains of GPC1. Colocates, in the presence of Cu(2+), to vesicles in para- and perinuclear regions, where both proteins under |
|
Protein Description | Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity).. | |
Protein Sequence | MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Phosphorylation | PKPGGWNTGGSRYPG CCCCCCCCCCCCCCC | 36.09 | 24719451 | |
36 | O-linked_Glycosylation | GGWNTGGSRYPGQGS CCCCCCCCCCCCCCC | 29.95 | OGP | |
38 | Phosphorylation | WNTGGSRYPGQGSPG CCCCCCCCCCCCCCC | 17.26 | 24719451 | |
43 | Phosphorylation | SRYPGQGSPGGNRYP CCCCCCCCCCCCCCC | 16.69 | 24719451 | |
44 | Hydroxylation | RYPGQGSPGGNRYPP CCCCCCCCCCCCCCC | 62.63 | 11032800 | |
95 | O-linked_Glycosylation | GWGQGGGTHSQWNKP CCCCCCCCCCCCCCC | 22.94 | 55828625 | |
107 | Phosphorylation | NKPSKPKTNMKHMAG CCCCCCCCCHHHHHH | 49.42 | 22210691 | |
109 | Sulfoxidation | PSKPKTNMKHMAGAA CCCCCCCHHHHHHHH | 3.69 | 19172188 | |
112 | Sulfoxidation | PKTNMKHMAGAAAAG CCCCHHHHHHHHHHH | 2.84 | 19172188 | |
128 | Phosphorylation | VVGGLGGYMLGSAMS HHCHHHHHHHHHHHC | 6.33 | 22210691 | |
129 | Sulfoxidation | VGGLGGYMLGSAMSR HCHHHHHHHHHHHCC | 3.75 | 19172188 | |
134 | Sulfoxidation | GYMLGSAMSRPIIHF HHHHHHHHCCCEEEC | 3.60 | 19172188 | |
135 | O-linked_Glycosylation | YMLGSAMSRPIIHFG HHHHHHHCCCEEECC | 34.32 | OGP | |
145 | Phosphorylation | IIHFGSDYEDRYYRE EEECCCCHHHHHHHH | 22.79 | - | |
154 | Sulfoxidation | DRYYRENMHRYPNQV HHHHHHHHHHCCCCC | 1.31 | 19172188 | |
166 | Sulfoxidation | NQVYYRPMDEYSNQN CCCEECCHHHCCCCC | 4.53 | 19172188 | |
181 | N-linked_Glycosylation | NFVHDCVNITIKQHT CCCEECEEEEEEECE | 31.83 | 12356908 | |
181 | N-linked_Glycosylation | NFVHDCVNITIKQHT CCCEECEEEEEEECE | 31.83 | 12356908 | |
193 | O-linked_Glycosylation | QHTVTTTTKGENFTE ECEEEEECCCCCCCH | 34.65 | 55835733 | |
194 | Ubiquitination | HTVTTTTKGENFTET CEEEEECCCCCCCHH | 63.23 | - | |
197 | N-linked_Glycosylation | TTTTKGENFTETDVK EEECCCCCCCHHHHH | 58.78 | 12356908 | |
197 | N-linked_Glycosylation | TTTTKGENFTETDVK EEECCCCCCCHHHHH | 58.78 | 17660510 | |
213 | Sulfoxidation | MERVVEQMCITQYER HHHHHHHHHHHHHHH | 0.83 | 19172188 | |
230 | GPI-anchor | QAYYQRGSSMVLFSS HHHHHCCCCCEECCC | 19.90 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
43 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRIO_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRIO_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00061 | Prion diseases; Creutzfeldt-Jacob disease (CJD); Gerstmann-Straussler disease (GSD); Gerstmann-Strau | |||||
H01243 | Huntington's disease-like syndrome | |||||
OMIM Disease | ||||||
Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), Gerstmann-Straussler disease (GSD), Huntington disease-like type 1 (HDL1) and kuru in humans | Note=PrP is found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases, like | |||||
scrapie in sheep and goat | ||||||
bovine spongiform encephalopathy (BSE) in cattle | ||||||
transmissible mink encephalopathy (TME) | ||||||
chronic wasting disease (CWD) of mule deer and elk | ||||||
(1) infectious (2) sporadic and (3) dominantly inherited forms. TME, CWD, BSE, FSE, EUE are all thought to occur after consumption of prion-infected foodstuffs. | feline spongiform encephalopathy (FSE) in cats and exotic ungulate encephalopathy (EUE) in nyala and greater kudu. The prion diseases illustrate three manifestations of CNS degeneration | |||||
123400 | ||||||
600072 | Fatal familial insomnia (FFI) | |||||
137440 | Gerstmann-Straussler disease (GSD) | |||||
603218 | Huntington disease-like 1 (HDL1) | |||||
245300 | Kuru (KURU) | |||||
606688 | Spongiform encephalopathy with neuropsychiatric features (SENF) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-197, AND MASSSPECTROMETRY. |